Evaxion Biotech Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 99.8%.

Top 21 shareholders own 39.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.72%	Merck Global Health Innovation Fund, LLC	542,288	US$742.9k	0%	100.0%
8.66%	Armistice Capital LLC	483,000	US$661.7k	23.2%	0.02%
7.76%	Niels Moeller	432,901	US$593.1k	1.83%	no data
7.68%	Andreas Mattsson	428,565	US$587.1k	2.1%	no data
1.46%	Marianne Sogaard	81,701	US$111.9k	157%	no data
1.32%	Christian Kanstrup	73,529	US$100.7k	14.3%	no data
0.77%	Invst, LLC	43,200	US$59.2k	-20%	0.01%
0.72%	Roberto Pineda	40,216	US$55.1k	0%	no data
0.38%	Steven Projan	21,111	US$28.9k	0%	no data
0.27%	Citadel Advisors LLC	14,825	US$20.3k	0%	no data
0.13%	Lars Holtug	7,352	US$10.1k	0%	no data
0.087%	Beacon Capital Management, LLC	4,863	US$6.7k	0%	no data
0.066%	Geode Capital Management, LLC	3,699	US$5.1k	1,450%	no data
0.066%	Lars Wegner	3,688	US$5.1k	-0.03%	no data
0.066%	Birgitte Rono	3,676	US$5.0k	0%	no data
0.066%	Jesper Nissen	3,676	US$5.0k	0%	no data
0.027%	BlackRock, Inc.	1,512	US$2.1k	0%	no data
0.014%	JPMorgan Chase & Co, Brokerage and Securities Investments	780	US$1.1k	-64.2%	no data
0.0052%	Rhumbline Advisers Ltd Partnership	290	US$397.4	0%	no data
0.0036%	Bo Karmark	200	US$274.3	0%	no data
0.00007%	SCBT Financial Corp., Asset Management Arm	4	US$5.3	0%	no data